Lv7
4830 积分 2021-06-08 加入
In Vivo CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus
17天前
已完结
Advancements and challenges in CAR T cell therapy in autoimmune diseases
24天前
已完结
BCMA-Targeted T-Cell Engager for Autoimmune Hemolytic Anemia after CD19 CAR T-Cell Therapy
1个月前
已完结
Advancements and challenges in CAR T cell therapy in autoimmune diseases
1个月前
已完结
Albumin-recruiting lipid nanoparticle potentiates the safety and efficacy of mRNA vaccines by avoiding liver accumulation
1个月前
已完结
Allogeneic CD5-specific CAR-T therapy for relapsed/refractory T-ALL: a phase 1 trial
2个月前
已完结
BCMA-Targeted T-Cell Engager for Autoimmune Hemolytic Anemia after CD19 CAR T-Cell Therapy
2个月前
已完结
Comparison of the safety profiles of CD19-targeting CAR T-cell therapy in patients with SLE and B-cell lymphoma
3个月前
已完结
In vivo CAR T cell generation to treat cancer and autoimmune disease
3个月前
已完结
InvivoCARTcellgenerationtotreatcancerandautoimmunedisease
3个月前
已关闭
皖公网安备34019202002308
